Abeona Therapeutics, Inc. (ABEO)
5.445
+0.06
(+1.21%)
USD |
NASDAQ |
Jun 09, 16:00
5.445
0.00 (0.00%)
After-Hours: 19:07
Abeona Therapeutics SG&A Expense (Quarterly) : 19.50M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 145.36M |
| Forum Markets, Inc. | 7.492M |
| Precigen, Inc. | 21.05M |
| PDS Biotechnology Corp. | 3.064M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |